KEYNOTE-189: Clinical Implications in Patients with Advanced Non-Squamous NSCLC and High (?50%) Tumor PD-L1 Expression (BMIC-031)

KEYNOTE-189: Clinical Implications in Patients with Advanced Non-Squamous NSCLC and High (?50%) Tumor PD-L1 Expression (BMIC-031)

BeaconMedIC

2 years
304 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Dr. Jack West reviews clinical results in patients with advanced non-squamous NSCLC and high tumor PD-L1 on the KEYNOTE-189 trial, providing thoughts on the clinical implications of these findings in management of these patients.
Up Next Autoplay